A T cell- and natural killer cell-specific, trypsin-like serine protease. Implications of a cytolytic cascade.

Gershenfeld, Howard K; Hershberger, R Jane; Mueller, Christoph; Weissman, Irving L (1988). A T cell- and natural killer cell-specific, trypsin-like serine protease. Implications of a cytolytic cascade. Annals of the New York Academy of Sciences, 532(1), pp. 367-379. New York Academy of Sciences 10.1111/j.1749-6632.1988.tb36354.x

[img] Text
Annals_NY_Academy_of_Science_-_August_1988_-_GERSHENFELD_-_A_T_Cell__and_Natural_Killer_Cell_Specific_Trypsin_like_Serine.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (780kB) | Request a copy

A new trypsin-like serine protease was cloned from both a murine cytotoxic T lymphocyte and a human PHA-stimulated peripheral blood lymphocyte cDNA library. In both the mouse and human system, this transcript had a T cell- and NK-specific distribution, being detected in cytotoxic T lymphocytes (CTL), some T-helper clones, and NK, but not in a variety of normal tissues. T-cell activation with Con A plus IL-2 induced mouse spleen cells to express this gene with kinetics correlating with the acquisition of cytolytic capacity. Both the mouse and human nucleotide sequences of this gene encoded an amino acid sequence with 25-40% identity to members of the serine protease family. The active-site "charge-relay" residues (His-57, Asp-102, and Ser-195 of the chymotrypsin numbering system) are conserved, as well as the trypsin-specific Asp (position 189 in trypsin). We reviewed the evidence of this serine protease's role in lymphocyte lysis and proposed a "lytic cascade." We discussed the biological and clinical implications of a cascade, proposing these enzymes as markers for cytolytic cells and as targets for rational drug therapy. Genetic and acquired deficits in the lethal hit-delivery system are considered as a basis for approaching some immunodeficiency states, including severe EBV infections, T-gamma leukemias, and T8+ lymphocytosis syndromes.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute of Pathology

UniBE Contributor:

Müller, Christoph (C)

Subjects:

500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health

ISSN:

1749-6632

Publisher:

New York Academy of Sciences

Language:

English

Submitter:

Christoph Müller

Date Deposited:

20 Sep 2022 09:51

Last Modified:

29 Mar 2023 23:38

Publisher DOI:

10.1111/j.1749-6632.1988.tb36354.x

PubMed ID:

3052212

BORIS DOI:

10.48350/172918

URI:

https://boris.unibe.ch/id/eprint/172918

Actions (login required)

Edit item Edit item
Provide Feedback